Johnson Matthey announces completion of Medical Device Components sale
Johnson Matthey announces completion of Medical Device Components sale
01 July 2024
Further to the announcement on 20th March 2024, Johnson Matthey Plc (JM) is pleased to announce that it has today completed the sale of its Medical Device Components business (MDC) in accordance with the terms of the sale agreement entered into between JM and Montagu Private Equity for cash consideration of US$700 million (£550 million) on a cash free debt free basis.
The board confirms its intention to return £250 million of the net proceeds from the sale of MDC by way of an on-market share buyback programme. This will commence later this week and further details will be announced in due course.
Enquiries:
Investor Relations
Martin Dunwoodie: Director of Investor Relations and Treasury, +44 20 7269 8241
Louise Curran: Head of Investor Relations, +44 20 7269 8235
Chris Wood: Senior Investor Relations Manager, +44 20 7269 8138
Media:
Sinead Keller: Group External Relations Director, +44 20 7269 8218
Harry Cameron: Teneo, +44 7799 152148
The board confirms its intention to return £250 million of the net proceeds from the sale of MDC by way of an on-market share buyback programme. This will commence later this week and further details will be announced in due course.
Enquiries:
Investor Relations
Martin Dunwoodie: Director of Investor Relations and Treasury, +44 20 7269 8241
Louise Curran: Head of Investor Relations, +44 20 7269 8235
Chris Wood: Senior Investor Relations Manager, +44 20 7269 8138
Media:
Sinead Keller: Group External Relations Director, +44 20 7269 8218
Harry Cameron: Teneo, +44 7799 152148
